Browse the corpus

REFERENCES Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol 2001; 131:590. Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusions. Semin Neurol 2000; 20:111. Cogan DG. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1973; 188:139. Wilkinson F. Auras and other hallucinations: windows on the visual brain. Prog Brain Res 2004; 144:305. Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347:794. Hikichi T, Yoshida A. Time course of development of posterior vitreous detachment in the fellow eye after development in the first eye. Ophthalmology 2004; 111:1705. Gass JD, Agarwal A, Scott IU. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol 2002; 134:329. Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 2003; 48:12. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 2004; 4:5. Schultz G, Melzack R. The Charles Bonnet syndrome: 'phantom visual images'. Perception 1991; 20:809. Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996; 47:408. Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Risk indicators for the Charles Bonnet syndrome. J Nerv Ment Dis 1998; 186:190. Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome. Surv Ophthalmol 2003; 48:58. Nesher R, Nesher G, Epstein E, Assia E. Charles Bonnet syndrome in glaucoma patients with low vision. J Glaucoma 2001; 10:396. Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 1995; 166:254. Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992; 149:1701.

Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 1995; 166:254. Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992; 149:1701. Kuzniecky R, Gilliam F, Morawetz R, et al. Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome. Epilepsia 1997; 38:175. Lepore FE. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology 1990; 40:444. Szucs A, Janszky J, Holló A, et al. Misleading hallucinations in unrecognized narcolepsy. Acta Psychiatr Scand 2003; 108:314. Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: a review. J Nerv Ment Dis 1997; 185:195. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12:221. Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004; 24:728. Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med 2002; 346:257. Wijman CA, Wolf PA, Kase CS, et al. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke 1998; 29:1539. Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991; 11:129. SELBY G, LANCE JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23:23. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8 Suppl 7:1. James MF, Smith JM, Boniface SJ, et al. Cortical spreading depression and migraine: new insights from imaging? Trends Neurosci 2001; 24:266. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119 ( Pt 2):355. Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry 1994; 57:1371.

James MF, Smith JM, Boniface SJ, et al. Cortical spreading depression and migraine: new insights from imaging? Trends Neurosci 2001; 24:266. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119 ( Pt 2):355. Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry 1994; 57:1371. Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology 1973; 23:570. Queiroz LP, Rapoport AM, Weeks RE, et al. Characteristics of migraine visual aura. Headache 1997; 37:137. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998; 121 ( Pt 10):1819. Evans RW, Daroff RB. Expert opinion: monocular visual aura with headache: retinal migraine? Headache 2000; 40:603. Mattsson P, Lundberg PO. Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura. Cephalalgia 1999; 19:479. Liu GT, Schatz NJ, Galetta SL, et al. Persistent positive visual phenomena in migraine. Neurology 1995; 45:664. Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997; 48:261. Haas DC. Prolonged migraine aura status. Ann Neurol 1982; 11:197. Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 2001; 41:823. Menon B. Symptomatic occipital epilepsy misdiagnosed as migraine. Headache 2007; 47:287. Eriksen MK, Thomsen LL, Olesen J. The Visual Aura Rating Scale (VARS) for migraine aura diagnosis. Cephalalgia 2005; 25:801. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000; 55:1588. San-Juan OD, Zermeño PF. Migraine with persistent aura in a Mexican patient: case report and review of the literature. Cephalalgia 2007; 27:456. Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke 1979; 10:299. Bien CG, Benninger FO, Urbach H, et al. Localizing value of epileptic visual auras. Brain 2000; 123 ( Pt 2):244. Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry 1999; 66:536. Kawai M, Cherches IM, Goldsmith IL. Visual illusory and hallucinatory phenomena in a patient with left occipital seizures. Neurology 2006; 67:1457.

Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry 1999; 66:536. Kawai M, Cherches IM, Goldsmith IL. Visual illusory and hallucinatory phenomena in a patient with left occipital seizures. Neurology 2006; 67:1457. Salanova V, Andermann F, Olivier A, et al. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Surgery of occipital lobe epilepsy. Brain 1992; 115 ( Pt 6):1655. Panayiotopoulos CP. Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine. Epileptic Disord 1999; 1:205. Andermann F, Zifkin B. The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine. Epilepsia 1998; 39 Suppl 4:S9. Zesiewicz TA, Baker MJ, Dunne PB, Hauser RA. Diffuse Lewy Body Disease. Curr Treat Options Neurol 2001; 3:507. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996; 53:1265. Assal F, Cummings JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 2002; 15:445. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001; 70:727. Del Ser T, McKeith I, Anand R, et al. Dementia with lewy bodies: findings from an international multicentre study. Int J Geriatr Psychiatry 2000; 15:1034. Manni R, Pacchetti C, Terzaghi M, et al. Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 2002; 59:1979. Kulisevsky J, Roldan E. Hallucinations and sleep disturbances in Parkinson's disease. Neurology 2004; 63:S28. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70:734. Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain 2006; 129:729. Sinforiani E, Terzaghi M, Pasotti C, et al. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients. Neurol Sci 2007; 28:96.

Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain 2006; 129:729. Sinforiani E, Terzaghi M, Pasotti C, et al. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients. Neurol Sci 2007; 28:96. Murgatroyd C, Prettyman R. An investigation of visual hallucinosis and visual sensory status in dementia. Int J Geriatr Psychiatry 2001; 16:709. Monastero R, Camarda C, Pipia C, Camarda R. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases. J Neurol Neurosurg Psychiatry 2007; 78:546. Terao T. Visual hallucinations in Alzheimer's disease: possible involvement of low visual acuity and dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 2000; 12:516. Gareri P, De Fazio P, Cotroneo A, et al. Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient. Arch Gerontol Geriatr 2007; 44 Suppl 1:199. Chapman FM, Dickinson J, McKeith I, Ballard C. Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry 1999; 156:1983. Taratuto AL, Piccardo P, Reich EG, et al. Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. Neurology 2002; 58:362. Armstrong RA. Creutzfeldt-Jakob disease and vision. Clin Exp Optom 2006; 89:3. Pachalska M, Kurzbauer H, MacQueen BD, et al. Neuropsychological features of rapidly progressive dementia in a patient with an atypical presentation of Creutzfeldt-Jakob Disease. Med Sci Monit 2001; 7:1307. Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005; 28:737. Piltz JR, Wertenbaker C, Lance SE, et al. Digoxin toxicity. Recognizing the varied visual presentations. J Clin Neuroophthalmol 1993; 13:275. Butler VP Jr, Odel JG, Rath E, et al. Digitalis-induced visual disturbances with therapeutic serum digitalis concentrations. Ann Intern Med 1995; 123:676. Wolin MJ. Digoxin visual toxicity with therapeutic blood levels of digoxin. Am J Ophthalmol 1998; 125:406. Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med 2006; 3:12.

Butler VP Jr, Odel JG, Rath E, et al. Digitalis-induced visual disturbances with therapeutic serum digitalis concentrations. Ann Intern Med 1995; 123:676. Wolin MJ. Digoxin visual toxicity with therapeutic blood levels of digoxin. Am J Ophthalmol 1998; 125:406. Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med 2006; 3:12. Dündar SO, Topalo Gcaron Lu A, Dündar M, Koçak I. Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3 months regular use. Eye (Lond) 2006; 20:810. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355:39. Dunn DW, Weisberg LA, Nadell J. Peduncular hallucinations caused by brainstem compression. Neurology 1983; 33:1360. Maiuri F, Iaconetta G, Sardo L, Buonamassa S. Peduncular hallucinations associated with large posterior fossa meningiomas. Clin Neurol Neurosurg 2002; 104:41. Lhermitte, J. Syndrome de la calotte pédonculaire. Les troubles psychosensorielles dans les lésions du mésencéphale. Rev Neurol 1922; 1359. Caplan LR. "Top of the basilar" syndrome. Neurology 1980; 30:72. Kölmel HW. Peduncular hallucinations. J Neurol 1991; 238:457. Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol 1987; 21:602. Roser F, Ritz R, Koerbel A, et al. Peduncular hallucinosis: insights from a neurosurgical point of view. Neurosurgery 2005; 57:E1068; discussion E1068. Benke T. Peduncular hallucinosis: a syndrome of impaired reality monitoring. J Neurol 2006; 253:1561. Kamalakannan D, Ravi S, Moudgil SS. Peduncular hallucinosis: unusual complication of cardiac catheterization. South Med J 2004; 97:999. O'Neill SB, Pentland B, Sellar R. Peduncular hallucinations following subarachnoid haemorrhage. Br J Neurosurg 2005; 19:359. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 2003; 114:2000. Feldman NT. Narcolepsy. South Med J 2003; 96:277. Bódizs R, Sverteczki M, Lázár AS, Halász P. Human parahippocampal activity: non-REM and REM elements in wake-sleep transition. Brain Res Bull 2005; 65:169. Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169:459.

Feldman NT. Narcolepsy. South Med J 2003; 96:277. Bódizs R, Sverteczki M, Lázár AS, Halász P. Human parahippocampal activity: non-REM and REM elements in wake-sleep transition. Brain Res Bull 2005; 65:169. Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169:459. Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000; 97:153. Cancelli I, Marcon G, Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol 2004; 19:577. Cochen V, Arnulf I, Demeret S, et al. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Brain 2005; 128:2535. Bowman, KM, Raymond, AF. A statistical study in the manic-depressive psychoses. Am J Psychiatry 1931; 88:299. Black DW, Nasrallah A. Hallucinations and delusions in 1,715 patients with unipolar and bipolar affective disorders. Psychopathology 1989; 22:28. Goodwin DW, Alderson P, Rosenthal R. Clinical significance of hallucinations in psychiatric disorders. A study of 116 hallucinatory patients. Arch Gen Psychiatry 1971; 24:76. Webster R, Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics 2000; 41:519. Burns A, Gallagley A, Byrne J. Delirium. J Neurol Neurosurg Psychiatry 2004; 75:362. Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 1984; 16:489. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991; 109:1673. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494. Topic 5255 Version 7.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1005-122.72.76.133-DEDEA7E9BD-S244013.14]